SCHEMBL9887648

SCHEMBL9887648

CC(=O)[C@@H]1CCCCC1C(=O)N(N)Cc1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.45
▸ HPGD P15428 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ LIN28A Q9H9Z2 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.37
▸ NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14707987 1.00 TSHR (0.45) TSHRHPGDRECQLRAB9ASMN1; SMN2
SCHEMBL12900870 1.00 TSHR (0.45) TSHRHPGDRECQLRAB9ASMN1; SMN2
SCHEMBL19625142 0.76 SMN1; SMN2 (0.50) TSHRSMN1; SMN2LMNAKMT2AALDH1A1
SCHEMBL23020652 0.74 HPGD (0.57) TSHRHPGDRECQLSMN1; SMN2CYP3A4
SCHEMBL20879998 0.74 HPGD (0.57) TSHRHPGDRECQLSMN1; SMN2CYP3A4
SCHEMBL47623 0.73 TSHR (0.43) TSHRHPGDRECQLRAB9ASMN1; SMN2
SCHEMBL47662 0.73 TSHR (0.43) TSHRHPGDRECQLRAB9ASMN1; SMN2
SCHEMBL18773876 0.69 TRPM8 (0.46) TSHRSMN1; SMN2KMT2AALDH1A1CYP1A2
SCHEMBL17468873 0.68 SMN1; SMN2 (0.41) TSHRRAB9ASMN1; SMN2KMT2AALDH1A1
SCHEMBL14981005 0.68 CTSB (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2596805-A1 Prodrug comprising a drug linker conjugate Ascendis Pharma A/S (DK) 2013-05-29 — — EP disclosed
WO-2011073234-A9 DRY GROWTH HORMONE COMPOSITION TRANSIENTLY LINKED TO A POLYMER CARRIER ASCENDIS PHARMA AS (DK) 2012-06-07 — — WO disclosed
WO-2011073234-A2 GROWTH HORMONE COMPOSITION ASCENDIS PHARMA AS (DK) 2011-06-23 — — WO disclosed
WO-2010100220-A1 INTERFERON ALPHA CARRIER PRODRUGS ASCENDIS PHARMA AS (DK) 2010-09-10 — — WO disclosed
WO-2009133137-A2 PEGYLATED RECOMBINANT HUMAN GROWTH HORMONE COMPOUNDS ASCENDIS PHARMA AS (DK) 2009-11-05 — — WO disclosed
WO-2009095479-A2 PRODRUG COMPRISING A SELF-CLEAVABLE LINKER ASCENDIS PHARMA AS (DK) 2009-08-06 — — WO disclosed
Send feedback